SCHEMBL16017182

SCHEMBL16017182

Cc1nc(C(=O)Nc2ccc(-c3cc(C(F)(F)F)nn3C)c(F)c2)c(C)o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 5/20 0.44
BACE2 Q9Y5Z0 3/20 0.44
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 2/20 0.42
STIM1 Q13586 1/20 0.41
ORAI1 Q96D31 1/20 0.41
POLB P06746 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
CRACR2A Q9BSW2 1/20 0.40
TRPV1 Q8NER1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16019788 0.91 DGAT1 (0.44) ALDH1A1HSD17B10STIM1ORAI1POLB
SCHEMBL16017197 0.87 ALDH1A1 (0.58) BACE1BACE2ALDH1A1HSD17B10STIM1
SCHEMBL14887486 0.85 DGAT1 (0.42) ALDH1A1HSD17B10KMT2A
SCHEMBL16019773 0.85 GRM1 (0.48) ALDH1A1STIM1ORAI1POLBHDAC3
SCHEMBL16019799 0.85 STIM1 (0.43) BACE1BACE2ALDH1A1HSD17B10STIM1
SCHEMBL16019771 0.83 ALDH1A1 (0.48) ALDH1A1HSD17B10STIM1ORAI1POLB
SCHEMBL16017205 0.82 GRM1 (0.52) KMT2ARAB9A
SCHEMBL16017189 0.81 STIM1 (0.51) ALDH1A1HSD17B10STIM1ORAI1POLB
SCHEMBL14887329 0.81 CRACR2A (0.60) STIM1ORAI1POLBCRACR2ARAB9A
SCHEMBL16017209 0.81 RAB9A (0.47) BACE1BACE2ALDH1A1HSD17B10STIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 BACE1 677/4885BACE2 527/4885ALDH1A1 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.